Further analysis using the Hemap database, which contains microarray-based transcriptomic profiles of various hematologic malignancies, showed that FOXP1 expression (log2 normalized intensity) was markedly elevated in patient samples of pre-B cell acute lymphoblastic leukemia (pre-B-ALL) and AML (Figure 1B). This evidence concerns the gene FOXP1 and hematologic disorder.